{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:40:02Z","timestamp":1794004802313,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CGRPG1N0011"],"award-info":[{"award-number":["CGRPG1N0011"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jmii.2025.11.001","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:40:55Z","timestamp":1763444455000},"page":"478-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Emergency department-initiated outpatient parenteral antimicrobial therapy in Taiwan: A retrospective cohort study on clinical outcomes and cost analysis"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8777-0483","authenticated-orcid":false,"given":"Yu-Kai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Tai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0753-4529","authenticated-orcid":false,"given":"Tien-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Hsuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jmii.2025.11.001_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.emc.2020.04.001","article-title":"Factors affecting emergency department crowding","volume":"38","author":"Kenny","year":"2020","journal-title":"Emerg Med Clin"},{"issue":"5","key":"10.1016\/j.jmii.2025.11.001_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2012.01.016","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years","volume":"39","author":"Barr","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jmii.2025.11.001_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2017.03.016","article-title":"Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service","volume":"51","author":"Durojaiye","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jmii.2025.11.001_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijantimicag.2008.07.016","article-title":"A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective","volume":"33","author":"Yong","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.11.001_bib5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s15010-024-02199-9","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study","volume":"52","author":"Schmidt-Hellerau","year":"2024","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.jmii.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s11739-021-02631-0","article-title":"The impact of an outpatient parenteral antibiotic therapy (OPAT) clinic for adults with cellulitis: an interrupted time series study","volume":"16","author":"Yadav","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.jmii.2025.11.001_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s15010-018-1126-4","article-title":"Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years","volume":"46","author":"Li","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.jmii.2025.11.001_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijid.2020.03.033","article-title":"Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan","volume":"95","author":"Hase","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.jmii.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijantimicag.2013.01.015","article-title":"An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort","volume":"41","author":"Seetoh","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jmii.2025.11.001_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae111","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis-what lessons can we learn?","volume":"6","author":"Reidy","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"2","key":"10.1016\/j.jmii.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jcpt.13550","article-title":"Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States","volume":"47","author":"Karimaghaei","year":"2022","journal-title":"J Clin Pharm Therapeut"},{"issue":"12","key":"10.1016\/j.jmii.2025.11.001_bib12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3111\/13696998.2015.1078339","article-title":"Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting","volume":"18","author":"Ektare","year":"2015","journal-title":"J Med Econ"},{"issue":"6","key":"10.1016\/j.jmii.2025.11.001_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14147","article-title":"Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: turkey perspective","volume":"75","author":"Bastug","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"11","key":"10.1016\/j.jmii.2025.11.001_bib14","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/cid\/ciac298","article-title":"Outpatient versus inpatient intravenous antimicrobial therapy: a population-based observational cohort Study of adverse events and costs","volume":"75","author":"Staples","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-018-0240-3","article-title":"Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study","volume":"19","author":"Huang","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.jmii.2025.11.001_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijantimicag.2019.04.008","article-title":"Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): a 10-year review from a large West London service","volume":"54","author":"Hatcher","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.jmii.2025.11.001_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00019053-200018050-00004","article-title":"Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective","volume":"18","author":"Wai","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.jmii.2025.11.001_bib18","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.sapharm.2021.01.009","article-title":"Clinical benefits and costs of an outpatient parenteral antimicrobial therapy service","volume":"17","author":"Bugeja","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.jmii.2025.11.001_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy745","article-title":"Infectious diseases Society of America Clinical Practice Guideline for the management of outpatient parenteral antimicrobial therapy","volume":"68","author":"Norris","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jmii.2025.11.001_bib20","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/emj.2010.094185","article-title":"Validation of the Taiwan triage and acuity scale: a new computerised five-level triage system","author":"Ng","year":"2011","journal-title":"Emerg Med J"},{"issue":"1","key":"10.1016\/j.jmii.2025.11.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pan\/mpr013","article-title":"Causal inference without balance checking: coarsened exact matching","volume":"20","author":"Iacus","year":"2012","journal-title":"Polit Anal"},{"key":"10.1016\/j.jmii.2025.11.001_bib23","series-title":"Causal inference: what if","first-page":"169","author":"Hern\u00e1n","year":"2020"},{"issue":"2","key":"10.1016\/j.jmii.2025.11.001_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/biom.13321","article-title":"Parametric g-formula implementations for causal survival analyses","volume":"77","author":"Wen","year":"2021","journal-title":"Biometrics"},{"issue":"6","key":"10.1016\/j.jmii.2025.11.001_bib25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jac\/dkp343","article-title":"Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective","volume":"64","author":"Chapman","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jmii.2025.11.001_bib26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jac\/dky474","article-title":"Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy","volume":"74","author":"Underwood","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jmii.2025.11.001_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/antibiotics14050451","article-title":"Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an ever-changing national health service (UK): benefits, barriers, and opportunities","volume":"14","author":"Durojaiye","year":"2025","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/j.jmii.2025.11.001_bib28","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/jac\/dky133","article-title":"Emergency department visits during outpatient parenteral antimicrobial therapy: a retrospective cohort study","volume":"73","author":"Shrestha","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jmii.2025.11.001_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12913-024-11017-9","article-title":"Exploring patients' perspectives: a mixed methods study on Outpatient Parenteral Antimicrobial Therapy (OPAT) experiences","volume":"24","author":"Peter","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"10.1016\/j.jmii.2025.11.001_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049733","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses","volume":"11","author":"Dimitrova","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jmii.2025.11.001_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijantimicag.2017.02.017","article-title":"Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at home units in Spain","volume":"50","author":"Gonz\u00e1lez-Ramallo","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jmii.2025.11.001_bib32","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jac\/dkp343","article-title":"Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective","volume":"64","author":"Chapman","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jmii.2025.11.001_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.37201\/req\/122.2020","article-title":"Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting","volume":"34","author":"Garc\u00eda-Queiruga","year":"2021","journal-title":"Rev Espa\u00f1ola Quimioter"},{"issue":"6","key":"10.1016\/j.jmii.2025.11.001_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2710.2001.00380.x","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost","volume":"26","author":"Bernard","year":"2001","journal-title":"J Clin Pharm Therapeut"},{"issue":"5","key":"10.1016\/j.jmii.2025.11.001_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf244","article-title":"Inpatient cost avoidance and uncompensated labor associated with different outpatient parenteral antimicrobial therapy care models","volume":"12","author":"Player","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2025.11.001_bib36","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2024.483","article-title":"Antimicrobial prescribing quality in Australian emergency departments: an analysis of the Hospital NAPS data set","volume":"5","author":"Zosky-Shiller","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.jmii.2025.11.001_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-025-02619-4","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy (OPAT) in Germany","author":"Tometten","year":"2025","journal-title":"Infection"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411822500194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411822500194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:46:53Z","timestamp":1783669613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168411822500194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S168411822500194X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.11.001","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency department-initiated outpatient parenteral antimicrobial therapy in Taiwan: A retrospective cohort study on clinical outcomes and cost analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}